WHO's 3-by-5 target.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control; D017954:Africa South of the Sahara / Q000453:epidemiology; D019380:Anti-HIV Agents / Q000600:supply & distribution / Q000627:therapeutic use*; D003906:Developing Countries / Q000191:economics / Q000706:statistics & numerical data*; D014943:Global Health; D015658:HIV Infections / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control; D006679:HIV Seropositivity / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D009937:Organizational Objectives; D015995:Prevalence; D014944:World Health Organization / Q000458:organization & administration
D019380:Anti-HIV Agents